Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Arbour, K. C.; Punekar, S.; Garrido-Laguna, I.; Hong, D. S.; Wolpin, B.; Pelster, M. S.; Barve, M.; Starodub, A.; Sommerhalder, D.; Chang, S.; Zhang, Y.; Salman, Z.; Wang, X.; Gustafson, C.; Spira, A. I. |
| Abstract Title: | Preliminary clinical activity of RMC-6236, a first-in-class, RAS-selective, tri-complex RAS-MULTI(ON) inhibitor in patients with KRAS mutant pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S458 |
| Language: | English |
| ACCESSION: | WOS:001087480200637 |
| DOI: | 10.1016/j.annonc.2023.09.1838 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 652O -- Source: Wos |
